In this final piece on aspirin for prevention of heart attack and stroke, Randall Stafford explains factors for doctors and patients to consider.
This In the Spotlight features Helio Costa, a geneticist who has developed an assay currently being used to help cancer patients.
Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.
On Stanford Radio's The Future of Everything, neurooncologist Michelle Monje discussed developments in the treatment of brain cancer in children.
Stanford clinicians take their cue from sports and election predictions to calculate an "in-game probability" of success when treating cancer patients.
Stanford researchers develop a machine-learning computer model for mammography assessment in hopes of aiding radiologists’ clinical decisions.
Many metastatic colorectal cancers appear "born to be bad," spreading to other organs before any diagnosis has been made, say Stanford researchers.
A patient worried that cancer may run in her family finds answers through genetic testing offering by Stanford Medicine's Humanwide project.
A recent Stanford Medicine event, Celebrating Cancer Survivors, brought survivors together to share a variety of stories about living with cancer.
In this In the Spotlight Q&A, radiology instructor Ahmed Nagy El Kaffas shares how a best friend and a trip to China shaped his early career.
Stanford researchers find that colorectal cancer is being diagnosed at later stages in younger patients, suggesting risk of the disease is growing.
In this essay, which originally appeared in Months to Years, writer Nicole Hardina reflects on caregiving for her partner who was dying of brain cancer.
In response to views that cigarettes were unhealthful, tobacco companies used images of medical professionals to sell their products.
A radio show features a Stanford oncologist discussing ultra-fast "flash" radiation therapy, which may kill cancer cells with less collateral damage.
The prevalence of genetic testing in the United States falls short of the recommended guidelines for women with ovarian cancer, new research indicates.
Study finds that starting colorectal cancer screening at age 45 would avert deaths, but testing more older people would be more beneficial.
